Childbirth Journey Through Virtual Reality: Pain, Anxiety and Birth Perception: A Randomized Controlled TrialBoyuk, Mervenur; Citak Bilgin, Nevin
2025 Research in Nursing & Health
doi: 10.1002/nur.22438pmid: 39749486
This study determines video's effect on pregnant women's pain, anxiety, and perception of labor using virtual reality glasses during the active and transition phases of childbirth. This randomized controlled study was conducted with 60 pregnant women (30 in each group) admitted to the delivery room of a hospital. The data were collected by personal information form, visual comparison scale‐pain, visual comparison scale‐anxiety, and perception of birth scale. While there was no significant difference between the groups in terms of pre‐intervention pain measurement in the active and transition phases, post‐intervention pain measurement in the active and transition phases in the intervention group was found to be significantly lower than the control group. Anxiety measurement was also found to be significantly lower in the intervention group in the active and transition phases than in the control group after the intervention. It was determined that in the intervention group, anxiety measurements tended to decrease after the intervention compared to the pre‐intervention period, while in the control group, anxiety measurements tended to increase continuously in the active and transition phases. Perceptions of birth in the postpartum period were similar. The use of virtual reality during childbirth reduces pain and anxiety at birth but does not affect the perception of birth. The use of virtual reality interventions as a nonpharmacological method can be included in childbirth preparation training.
Impacts of Lifestyle Intervention by a Nurse‐Led Smartphone Application on Blood Pressure, Weight, and Pregnancy Outcomes in Pregnant Women With Gestational Hypertension: A Randomized Controlled TrialGuo, Jingjing; Lu, Xiaoqin; Zhou, Yuheng; Liang, Yulian; Wang, Shiying; Chen, Cong; Ran, Xuerong; Zhang, Jing; Ou, Chun‐Quan; Zhai, Jinguo
2025 Research in Nursing & Health
doi: 10.1002/nur.22439pmid: 39804028
High blood pressure and excess weight during pregnancy can have adverse outcomes. This randomized controlled trial evaluated the effects of a nurse‐led smartphone application‐based lifestyle intervention on blood pressure, body weight, and pregnancy outcomes in pregnant women with gestational hypertension between August and December 2023. Pregnant women, between 20 and 28 weeks of gestation, were allocated to the intervention or control group. Control group (n = 99) received standard high‐risk pregnancy management, while intervention group (n = 96) also received lifestyle guidance via a nurse‐led smartphone application. Intervention group experienced longer gestations (p = 0.007), higher neonatal weights (p = 0.028), and lower incidences of pre‐eclampsia (p < 0.001), small for gestational age infants (p = 0.003), and preterm births (p = 0.023) compared to control group. The mixed‐effect models for repeated measures showed that the nurse‐led smartphone application intervention had no impact on body mass index, while significantly reducing systolic and diastolic blood pressure measurements (β = −1.666, 95% confidence interval, CI: −2.814 to −0.519, p = 0.005 and β = −2.247, 95% CI: −3.349 to −1.145, p < 0.001, respectively). Both systolic and diastolic blood pressures showed a downward trend from 28 weeks (p < 0.05). The nurse‐led smartphone application‐based lifestyle intervention significantly reduced adverse pregnancy outcomes and positively influenced blood pressure management in pregnant women with gestational hypertension.
Tracking Survivors With Long COVID: Method, Implementation, and Results of an Observational StudyWu, Horng‐Shiuann; Pathak, Dola; Hall, Mandy; Given, Charles W.
2025 Research in Nursing & Health
doi: 10.1002/nur.22437
While the coronavirus disease 2019 (COVID‐19) pandemic has declined, many survivors continue to suffer debilitating symptoms, such as fatigue, pain, and foggy thoughts. Sustained COVID‐19 symptoms, or Long COVID, challenge health care resources and economic recovery. This article describes the methodology, implementation, and results of an observational study investigating how time since diagnosis may affect lingering symptoms among the adult COVID‐19 population. The descriptive distribution and overall symptoms experience by individuals' characteristics were examined. Random samples from two patient cohorts (n = 147 in 2020−2021 and n = 137 in 2021−2022) were recruited from a COVID‐19 patient registry in mid‐Michigan. Samples were drawn from a pool of patients ≥ 3 months following their COVID‐19 diagnosis. Overall symptoms experience (number, severity, interference) was self‐reported using a comprehensive symptom inventory. The findings showed that 66% of the 2020−2021 cohort and 47% of the 2021−2022 cohort reported ≥ 1 lingering symptom with an average of 11.2 (±3.0) and 8.9 (±3.3) months, respectively, after COVID‐19 diagnosis. Females reported significantly more symptoms (p = 0.018), higher symptom severity (p = 0.008) and interference (p = 0.007) compared to males. Compared to patients admitted to emergency departments, outpatients reported significantly lower symptom severity (p = 0.020) and less symptom interference (p = 0.018). Our analyses showed that a moderate proportion (43%) of adults remained symptomatic nearly a year after COVID‐19 infection and time since diagnosis did not affect symptom experience in either cohort. Female sex and admission setting are important factors to consider for managing and studying Long COVID.